Is age-related maculopathy associated with Alzheimer's disease? The Rotterdam Study

American Journal of Epidemiology

Volumn 150, Issue 9, 1999, Pages 963-968

  Klaver, Caroline C W ^a   Ott, Alewijn ^a   Hofman, Albert ^a   Assink, Jacqueline J M ^a,b   Breteler, Monique M B ^a   De Jong, Paulus T V M ^a,b,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Aging; Alzheimer disease; Atherosclerosis; Comorbidity; Incidence; Macular degeneration; Neurodegenerative diseases; Smoking

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PREVALENCE; RETINA MACULOPATHY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 0033230210     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010105     Document Type: Article

References (37)

1. Vingerling JR, Dielemans I, Hofman A, et al. Prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995;102:205-10.
2. Ott A, Breteler MBB, van Harskamp F, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam Study. BMJ 1995;310:970-3.
3. Pauleikhoff D, Wessing A, Marshall J, et al. Lipids in Bruch's membrane: a pathogenetic factor in age-related pigment epithelium detachment. Chibret Int J Ophthalmol 1992;9:62-9.
4. Kliffen M, Mooy CM, Luider TM, et al. Analysis of carbohydrate structures in basal laminar deposit in aging human maculae. Invest Ophthalmol Vis Sci 1994;35:2901-5.
5. Kliffen M, de Jong PTVM, Luider TM. Protein analysis of human maculae in relation to age-related maculopathy. Lab Invest 1995;73:267-72.
6. Kliffen M, Mooy CM, Luider TM, et al. Identification of glycosaminoglycans in age-related macular deposits. Arch Ophthalmol 1996;114:1009-14.
7. Sarks SH. Ageing and degeneration in the macular area: a clinico-pathological study. Br J Ophthalmol 1976;60:324-41.
8. Sarks JP, Sarks SH, Killingsworth MC. Evolution of soft drusen in age-related macular degeneration. Eye 1994;8: 269-83.
9. Holz FG, Wolfensberger TJ, Piguet B, et al. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology 1994;101:1522-8.
10. Mrak RE, Griffin WST, Graham DI. Aging-associated changes in the human brain. J Neuropathol Exp Neurol 1997;56: 1269-75.
11. Giannakopoulos P, Hof PR, Michel JP, et al. Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res Brain Res Rev 1997;25:217-45.
12. Berg L, McKeel DW, Miller P, et al. Neuropathological indexes of Alzheimer's disease in demented and ND persons aged 80 years and older. Arch Neurol 1988;45:789-93.
13. Morris JC, Storandt M, McKeel DW Jr, et al. Cerebral amyloid deposition and diffuse plaques in abnormal aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-19.
14. Hofman A, Grobbee DE, de Jong PTVM, et al. Determinants of diseases and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991;7:403-22.
15. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39: 367-74.
16. McKahnn G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
17. Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population of 60-year-old men and women. J Chronic Dis 1981;34:261-9.
18. Fowkes FGR, Housely E, Cawood EH, et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-92.
19. Hofman A, Grobbee DE, de Jong PTVM, et al. Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-4.
20. Wenham PR, Price WH, Blundell G. Apolipoprotein E geno-typing by one stage PCR. Lancet 1991;337:1158-9.
21. Van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-8.
22. Ott A, Breteler MMB, van Harskamp F, et al. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 1998; 147:574-80.
23. Seddon JM, Willett WC, Speizer FE, et al. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996;276:1141-6.
24. Christen WG, Glynn RJ, Manson JE, et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 1996;276:1147-51.
25. Klein R, Klein BEK, Moss SE. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am J Epidemiol 1998;147:103-10.
26. Lee PN. Smoking and Alzheimer's disease: a review of the epidemiologic evidence. Neuroepidemiology 1994;13:131-44.
27. Ott A, Slooter AJC, Hofman A, et al. Smoking and the risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 1998;351:1840-3.
28. Langhans M, Michelson G, Groh MJM. Effect of breathing 100% oxygen on retinal and optic nerve head capillary blood flow in smokers and non-smokers. Br J Ophthalmol 1997;81:365-9.
29. Zhu B, Parmley WW. Hemodynamic and vascular effects of active and passive smoking. Am Heart J 1995;130:1270-5.
30. Holbrook JH. Nicotine addiction. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Harrison's principles of internal medicine. 13th ed. New York, NY: McGraw-Hill, 1994:2433-7.
31. Vingerling JR, Dielemans I, Bots ML, et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995;142:404-9.
32. Pauleikhoff D, Chen JC, Chisholm IH, et al. Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol 1990;109:211-17.
33. Ellis RJ, Olichney JM, Thal LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience. Part XV. Neurology 1996;46:1592-6.
34. Strittmacher WJ, Saunders AM, Schmechel DE, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:1977-81.
35. Tsai MS, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 1994;54:643-9.
36. Souied EH, Benlian P, Amouyel P, et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998;125:353-9.
37. Klaver CCW, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998;63:200-6.